Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age21-49
SponsorBritish University In Egypt
About this trial
The aim of the study is to evaluate the anti-bacterial potential of Nano Calcium Hydroxide as an intracanal medication in primary endodontic treatment of permanent molars.
Eligibility criteria
Qualifiers
healthy males and females.
age range between 21-49.
patients with no physical disability or psychological problems.
patients presenting with single permanent molar with signs and/or symptoms of apical periodontitis, and having Periapican index ≥ 2.
Disqualifiers
pregnant women.
patients with immune-compromised disease.
patients with complicated systemic diseases.
patients who took antibiotics within a period of 1 month.
Trial design
Treatments tested in this trial
- Calcium hydroxide
- nano calcium hydroxide
Treatment groups
54 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov